ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
ADIG | Adipogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOR1 | Adiponectin receptor 1 | Predicted membrane proteins
| | | | | Expressed in all |
ADIPOR2 | Adiponectin receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADPGK | ADP-dependent glucokinase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2A | Adrenoceptor alpha 2A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADRA2B | Adrenoceptor alpha 2B | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB2 | Adrenoceptor beta 2, surface | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADSSL1 | Adenylosuccinate synthase like 1 | Enzymes Plasma proteins
| | | | | Tissue enriched |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AE000662.92 | Uncharacterized protein | Predicted membrane proteins
| | | | | Not detected |
AF196779.12 | WD repeat domain phosphoinositide-interacting protein 4 | Predicted membrane proteins
| | | | | Not detected |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGER | Advanced glycosylation end product-specific receptor | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT1 | 1-acylglycerol-3-phosphate O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | Enzymes Predicted membrane proteins
| | | | | Mixed |
AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT6 | 1-acylglycerol-3-phosphate O-acyltransferase 6 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AGTR2 | Angiotensin II receptor, type 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AIFM2 | Apoptosis-inducing factor, mitochondrion-associated, 2 | Mitochondrial proteins
| | | | | Expressed in all |
AIG1 | Androgen-induced 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP1 | A kinase (PRKA) anchor protein 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
AL021546.6 | Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial | | | | | | Not detected |
AL109659.1 | HCG1780467; PRO0529; Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AL132989.1 | | Predicted membrane proteins
| | | | | Not detected |
AL133262.1 | | Predicted membrane proteins
| | | | | Not detected |
AL138815.2 | Uncharacterized protein | Predicted membrane proteins
| | | | | Not detected |
AL162407.1 | CDNA FLJ20147 fis, clone COL07954; HCG1781466; Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AL163636.6 | Homo sapiens ribonuclease, RNase A family, 4 (RNASE4), transcript variant 4, mRNA. | Predicted secreted proteins
| | | | | Mixed |
AL353791.1 | | | | | | | Tissue enhanced |